In one paragraphArticle in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Anikó BozsikDepartment of Molecular Genetics and National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Center, 1122 Budapest, Hungary.ORCID 0000-0001-5410-9173 Henriett ButzDepartment of Molecular Genetics and National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Center, 1122 Budapest, Hungary.ORCID 0000-0003-1664-409X Vince Kornél GrolmuszDepartment of Molecular Genetics and National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Center, 1122 Budapest, Hungary.
Petra NagyDepartment of Molecular Genetics and National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Center, 1122 Budapest, Hungary.ORCID 0009-0000-4336-8444 Tímea PóczaDepartment of Molecular Genetics and National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Center, 1122 Budapest, Hungary.
Erika TóthDepartment of Molecular Pathology, National Institute of Oncology, Comprehensive Cancer Center, 1122 Budapest, Hungary.ORCID 0000-0003-2054-8447 Erzsébet CsernákDepartment of Molecular Pathology, National Institute of Oncology, Comprehensive Cancer Center, 1122 Budapest, Hungary.
Attila PatócsDepartment of Molecular Genetics and National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Center, 1122 Budapest, Hungary.ORCID 0000-0001-7506-674X János PappDepartment of Molecular Genetics and National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Center, 1122 Budapest, Hungary.
Funding
COST Action CA20122 Harmonisation CA20122Hungarian Academy of Sciences Bolyai research fellowshipHungarian Thematic Excellence Program TKP2021-EGA-44János Bolyai Postdoctoral Scholarship BO/00141/21National Research, Development and Innovation Fund of the Ministry of Culture and Innovation under the National Laboratories Program (National Tumour Biology Laboratory) 2022-2.1.1-NL-2022-00010New National Excellence Program Bolyai+ Scholarship ÚNKP-23-5-SE-16New National Excellence Program of the Ministry of Human Capacities ÚNKP-23-5-SE-4
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
germline pathogenic varianthereditary breast cancerstructural variationtarget-primed reverse transcriptiontransposon insertion
Identifiers
PMID41375073
PMCPMC12691391
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390